title: Committee Opinion No. 479: Methamphetamine abuse in women of reproductive age.
abstract: Methamphetamine abuse has continued to increase in the United States since the late 1980s with its use spreading from the West Coast to areas across the country. Methamphetamine use in pregnancy endangers the health of the woman and increases the risk of low birth weight and small for gestational age babies and such use may increase the risk of neurodevelopmental problems in children. All pregnant women should be asked about their drug and alcohol use. Urine toxicology screening may be useful in detecting methamphetamine and other substance abuse during pregnancy, but this screening should only be done with maternal consent after counseling regarding the potential ramifications of a positive test result. Women reporting continuing use of methamphetamine in pregnancy should be referred for treatment and followed up with serial ultrasound examinations to assess fetal growth.
mesh_terms: D019969:Amphetamine-Related Disorders / Q000175:diagnosis / Q000628:therapy; D001942:Breast Feeding; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D005260:Female; D006801:Humans; D018811:Maternal Exposure; D008694:Methamphetamine / Q000009:adverse effects*; D009774:Obstetrics / Q000592:standards; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects
chemical_list: D000697:Central Nervous System Stimulants; D008694:Methamphetamine